Search Results 2221-2230 of 16169 for Epilepsy (Partial Onset)
Pediatric patients with ongoing seizures and/or neurological abnormalities;; Hemodynamically unstable patients;; Complex clinical situations requiring medical ...
Participation eligibility · Prior significant neurological disorder (e.g., dementia, seizure disorder, moderate or severe traumatic brain injury) · We will ...
No prior pharmacologic androgen ablation for prostate cancer unless the onset of androgen ablation is ≤ 45 days prior to the date of registration. No ...
Patients with a history of severe motion sickness, seizure disorder, or unwillingness to participate will not be included. In addition, if they are too ...
This is an open label, multi-center, Phase Ib dose escalation study of BBI608 administered in combination with either FOLFOX6 with and without bevacizumab, or ...
Olaparib and onalespib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Participation eligibility. Participant ...
The purpose of this study is to evaluate the safety and effectiveness of repeated subcutaneous (SC) administrations of Lanadelumab in preventing angioedema ...
... seizures, etc.). Is still alive in the ICU at the time that the clinical team approaches the primary caregiver about possible recruitment. Has a prognosis ...
So again, a positive Carnett sign would be someone who has worsening of their abdominal tenderness in a focal area with tensing of their abdominal wall ...
Current treatment of seizures with clobazam, valproate, or other antiepileptic medications. Participating Mayo Clinic locations. Study statuses change often ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The deadline to have twice the impact to advance healthcare research is May 15.